SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-24-000538
Filing Date
2024-08-19
Accepted
2024-08-19 19:02:21
Documents
1
Group Members
BERYL CAPITAL MANAGEMENT LPDAVID A. WITKIN

Document Format Files

Seq Description Document Type Size
1 g1therapeutics13g.htm SC 13G 67381
  Complete submission text file 0000935836-24-000538.txt   69181
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90214 | Film No.: 241222215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277
Business Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277 9174461561
Beryl Capital Management LLC (Filed by) CIK: 0001719307 (see all company filings)

IRS No.: 474641111 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G